Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients

Bram L.T. Ramaekers, Manuela A. Joore, Béranger Lueza, Julia Bonastre, Audrey Mauguen, Jean Pierre Pignon, Cecile Le Pechoux, Dirk K.M. De Ruysscher, R. Arriagada, K. Bae, D. Ball, M. Baumann, K. Behrendt, C. P. Belani, J. Beresford, J. Bishop, J. A. Bonner, H. Choy, S. E. Dahlberg, D. De RuysscherS. Dische, P. Fournel, R. Koch, C. Le Péchoux, S. J. Mandrekar, F. Mornex, M. Nankivell, G. Nelson, M. K. Parmar, R. Paulus, J. P. Pignon, M. I. Saunders, W. Sause, S. E. Schild, A. T. Turrisi, A. Zajusz, Janneke P.C. Grutters

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences